ConductScience.org, home

Comparison · NCT03106870-0369ac9a

Oral Metformin and Insulin vs Insulin Therapy Only: Number of Participants With a Macrosomic Baby

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Oral Metformin and Insulin vs Insulin Therapy Only: Number of Participants With a Macrosomic Baby. Trial comparisons, record NCT03106870-0369ac9a. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03106870-0369ac9a

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.1610.07090.326wilson
Risk in group 20.3870.2370.562wilson
Risk difference, group 1 minus group 2-0.226-0.422-0.00293newcombe hybrid score
Risk ratio, group 1 over group 20.4170.1671.04log
Odds ratio, group 1 over group 20.3040.09181.01log
Number needed to treat, for one fewer participant with the outcome on Oral Metformin and Insulin than on Insulin Therapy Only4.432.37341from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Oral Metformin and Insulin
Intervention 'Insulin Mixtard' and Intervention 'metformin' had included~Insulin Mixtard: Insulin dose:~* 0.7 IU/Kg (at the second trimester of pregnancy).~* 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration.~Metformin: Oral metformin at a dose of 1500 mg divided into three doses, were taken with meals, in addition to insulin.~If the target blood glucose concentrations were not attained, the dose of metformin was raised to 2000 mg per day.
531OG000
Group 2Insulin Therapy Only
Intervention 'Insulin Mixtard' had included~Insulin Mixtard: Insulin dose:~* 0.7 IU/Kg (at the second trimester of pregnancy).~* 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration.
1231OG001

Outcome

Type
SECONDARY
Title
Number of Participants With a Macrosomic Baby
Description
Fetal macrosomia has been defined birth weight greater than 4500 gm
Time frame
24 hours after delivery
Population

Source ClinicalTrials.gov

Trial

Title
Adding Metformin to Insulin in Controlling Pregestational and Gestational Diabetes Mellitus
NCT number
NCT03106870
Phases
NA
Conditions
Gestational Diabetes Mellitus in Pregnancy
Interventions
Insulin Mixtard, Metformin
Lead sponsor
Ain Shams University
Results first posted
2017-06-14

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03106870-0369ac9a